poisar

Stock

Vir Biotechnology, Inc. VIR

$11.28+1.67%

Overview

VIR market data

Price History

VIR price chart · 3M
O
10.97
H
11.45
L
10.87
C
11.28
Vol
99,739.00
Source
US equities market feed
Observed
Aug 27, 2026, 12:00 AM
Cadence
Five-minute page cache; daily and stored hourly bars
Status
fresh

Key Stats & Performance

Open
$10.97
Previous Close
$11.10
Day High
$11.45
Day Low
$10.87
52 Week High
$11.45
52 Week Low
$8.17
7 Day Return
+22.41%
30 Day Return
+27.46%
90 Day Return
+18.36%
1 Year Return
+11.79%
Daily Notional Volume
$1.1M
Latest daily bar volume multiplied by its closing price.

Valuation & Profitability

Provider-backed
P/E (TTM)
Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
Forward P/E
P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
EPS (TTM)
-$3.16
Diluted earnings per share over the trailing twelve months.
Beta
1.60
Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
Dividend Yield
Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
Profit Margin
-41.5%
Net income divided by revenue. Comparable within a sector, less so across sectors.
52w range
$4.35 – $11.66
Lowest and highest closing prices over the past 52 weeks.
Analyst Target
Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.

Display-only. Refreshed once per symbol per 24 hours · market cap $1.5B · P/B 1.10 · P/S 4.95.

Company News

5 captured
Vir Biotechnology shares are trading higher after the company reported better-than-expected Q2 financial results.Benzinga · Aug 6, 2026, 12:54 PM
Vir Biotechnology Q2 EPS $0.47 Beats $0.18 Estimate, Sales $238.946M Beat $216.456M EstimateBenzinga · Aug 5, 2026, 8:15 PM
Vir Biotechnology Appoints Brent Sabatini To Interim Principle Financial Officer Effective July 23 As The Company Begins Search For CFOBenzinga · Jul 24, 2026, 12:32 PM
8-K filing — Vir Biotechnology, Inc. (VIR)SEC EDGAR · Jul 24, 2026, 12:31 PM
Morgan Stanley Maintains Overweight on Vir Biotechnology, Raises Price Target to $27Benzinga · Jun 11, 2026, 12:30 PM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock